Release Date: 21/12/15 09:22 Summary: Broadspectrum upgrades guidance Price Sensitive: Yes Download Document 82.76KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%